VELCADE
Live / Registered — Registered and renewed (as of 22 Apr 2024)
What this means for you
Registered since 16 Dec 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Dec 2023).
Record
- Serial number
- 76397478
- Registration number
- 2795745
- Mark type
- Word mark
- Filed
- 19 Apr 2002
- Published for opposition
- 29 Oct 2002
- Registered
- 16 Dec 2003
- Next maintenance due
- 16 Dec 2023
- Attorney of record
- Nancy DiConza
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals, namely, proteasome inhibitors; and pharmaceutical preparations for treatment of myelomas, leukemias, and cancers; pharmaceutical preparations for use in chemotherapy
Owner
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 22 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 22 Apr 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 22 Apr 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Dec 2023 — TEAS SECTION 8 & 9 RECEIVED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Jun 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
- 06 Jun 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 06 Jun 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 06 Jun 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 May 2013 — TEAS SECTION 8 & 9 RECEIVED
- 25 Mar 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Mar 2009 — ASSIGNED TO PARALEGAL
- 20 Mar 2009 — TEAS SECTION 8 & 15 RECEIVED